<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mississippi Business Journal &#187; Keith Thompson</title>
	<atom:link href="http://msbusiness.com/blog/tag/keith-thompson/feed/" rel="self" type="application/rss+xml" />
	<link>http://msbusiness.com</link>
	<description>Mississippi Business Journal</description>
	<lastBuildDate>Mon, 20 May 2013 18:59:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Thompson named investigator</title>
		<link>http://msbusiness.com/blog/2012/08/05/thompson-named-investigator/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=thompson-named-investigator</link>
		<comments>http://msbusiness.com/blog/2012/08/05/thompson-named-investigator/#comments</comments>
		<pubDate>Sun, 05 Aug 2012 06:01:04 +0000</pubDate>
		<dc:creator>MBJ Staff</dc:creator>
				<category><![CDATA[Newsmakers]]></category>
		<category><![CDATA[Forrest General Hospital]]></category>
		<category><![CDATA[Hattiesburg Clinic]]></category>
		<category><![CDATA[Keith Thompson]]></category>

		<guid isPermaLink="false">http://msbusiness.com/?p=60706</guid>
		<description><![CDATA[<p>Hattiesburg Clinic’s Vascular Specialists Department, in conjunction with Forrest General Hospital, is participating in a national, FDA-approved carotid stenting trial called EV3. Keith Thompson, D.O., a vascular specialist with Hattiesburg Clinic, has been selected to serve as site principal investigator. Thompson has also recently participated in other FDA trials including minimally invasive percutaneous aortic aneurysm [...]</p><p>The post <a href="http://msbusiness.com/blog/2012/08/05/thompson-named-investigator/">Thompson named investigator</a> appeared first on <a href="http://msbusiness.com">Mississippi Business Journal</a>.</p>]]></description>
		<wfw:commentRss>http://msbusiness.com/blog/2012/08/05/thompson-named-investigator/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thompson tapped for study</title>
		<link>http://msbusiness.com/blog/2010/03/14/thompson-tapped-for-study/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=thompson-tapped-for-study</link>
		<comments>http://msbusiness.com/blog/2010/03/14/thompson-tapped-for-study/#comments</comments>
		<pubDate>Sun, 14 Mar 2010 06:00:42 +0000</pubDate>
		<dc:creator>MBJ Staff</dc:creator>
				<category><![CDATA[Newsmakers]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Hattiesburg Clinic]]></category>
		<category><![CDATA[Keith Thompson]]></category>

		<guid isPermaLink="false">http://msbusiness.com/?p=20556</guid>
		<description><![CDATA[<p>Hattiesburg Clinic vascular surgeon Keith Thompson, D.O., F.A.C.O.S., has been selected to serve as a principle investigator in a nationwide Food and Drug Administration approved clinical study evaluating the minimally invasive repair of abdominal aortic aneurysms. The study sponsored by Endologix, of Irvine, Calif., involves 19 centers across the country including facilities such as: Cleveland [...]</p><p>The post <a href="http://msbusiness.com/blog/2010/03/14/thompson-tapped-for-study/">Thompson tapped for study</a> appeared first on <a href="http://msbusiness.com">Mississippi Business Journal</a>.</p>]]></description>
		<wfw:commentRss>http://msbusiness.com/blog/2010/03/14/thompson-tapped-for-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
